U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 2

Figure 2. From: Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.

2-Arachidonoylglycerol contents in the limbic forebrain and midbrain of rats during chronic exposure (alcoholization), abstinence, or voluntary consumption (relapse) of ethanol. See details in the text. Data are expressed as means±s.e.m. of four determinations per group and were assessed by one-way analysis of variance followed by the Bonferroni multiple comparison test (different letters between two groups mean that their differences reached statistical significance: P<0.05).

Sara González, et al. Br J Pharmacol. 2004 Oct;143(4):455-464.
2.
Figure 1

Figure 1. From: Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.

Anandamide contents in the limbic forebrain and midbrain of rats during chronic exposure (alcoholization), abstinence, or voluntary consumption (relapse) of ethanol. See details in the text. Data are expressed as means±s.e.m. of four determinations per group and were assessed by one-way analysis of variance followed by the Bonferroni multiple comparison test (different letters between two groups mean that their differences reached statistical significance: P<0.05).

Sara González, et al. Br J Pharmacol. 2004 Oct;143(4):455-464.
3.
Figure 3

Figure 3. From: Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.

Voluntary liquid and ethanol intake, and ethanol preference, in abstinent rats allowed to reinstate alcohol-drinking behavior and administered with Δ9-THC, CP55,940, or SR141716, alone or in combination. See details on treatments in the text. Data correspond to the percentage of intake or preference after treatment versus the data collected the day before treatment, and are expressed as means±s.e.m. of more than six determinations per group. Data were assessed by one-way analysis of variance followed by the Bonferroni multiple comparison test (different letters between two groups mean that their differences reached statistical significance: P<0.05).

Sara González, et al. Br J Pharmacol. 2004 Oct;143(4):455-464.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center